Stableford Capital II’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.51M | Sell |
7,098
-405
| -5% | -$414K | 2.95% | 8 |
|
|
2026
Q1 | $6.9M | Buy |
7,503
+53
| +0.7% | +$53.7K | 2.56% | 10 |
|
|
2025
Q4 | $8.01M | Sell |
7,450
-89
| -1% | -$85.1K | 2.89% | 5 |
|
|
2025
Q3 | $5.75M | Buy |
7,539
+215
| +3% | +$160K | 2.08% | 11 |
|
|
2025
Q2 | $5.95M | Buy |
7,324
+2
| +0% | +$1.55K | 2.24% | 10 |
|
|
2025
Q1 | $6.15M | Buy |
7,322
+94
| +1% | +$78.2K | 2.6% | 11 |
|
|
2024
Q4 | $5.58M | Sell |
7,228
-2,600
| -26% | -$2.15M | 2.21% | 9 |
|
|
2024
Q3 | $9.16M | Buy |
9,828
+358
| +4% | +$322K | 3.66% | 3 |
|
|
2024
Q2 | $8.58M | Sell |
9,470
-158
| -2% | -$126K | 3.37% | 8 |
|
|
2024
Q1 | $7.49M | Buy |
9,628
+635
| +7% | +$452K | 3.01% | 10 |
|
|
2023
Q4 | $5.72M | Sell |
8,993
-148
| -2% | -$86.4K | 2.45% | 10 |
|
|
2023
Q3 | $5.19M | Sell |
9,141
-4,028
| -31% | -$2.08M | 2.39% | 9 |
|
|
2023
Q2 | $6.87M | Buy |
+13,169
| New | +$5.52M | 3.04% | 7 |
|
|
2023
Q1 | – | Sell |
-13,491
| Closed | -$4.72M | – | 118 |
|
|
2022
Q4 | $4.72M | Sell |
13,491
-154
| -1% | -$54.6K | 2.56% | 12 |
|
|
2022
Q3 | $4.65M | Sell |
13,645
-26
| -0.2% | -$8.24K | 2.25% | 14 |
|
|
2022
Q2 | $4.12M | Sell |
13,671
-531
| -4% | -$159K | 1.91% | 17 |
|
|
2022
Q1 | $4.38M | Sell |
14,202
-349
| -2% | -$89.8K | 1.85% | 14 |
|
|
2021
Q4 | $3.5M | Buy |
14,551
+1,280
| +10% | +$324K | 1.47% | 19 |
|
|
2021
Q3 | $3.14M | Buy |
13,271
+2,062
| +18% | +$509K | 1.59% | 16 |
|
|
2021
Q2 | $2.57M | Hold |
11,209
| – | – | 1.23% | 21 |
|
|
2021
Q1 | $2.09M | Hold |
11,209
| – | – | 1.06% | 27 |
|
|
2020
Q4 | $1.89M | Hold |
11,209
| – | – | 1.11% | 25 |
|
|
2020
Q3 | $1.66M | Hold |
11,209
| – | – | 1.13% | 27 |
|
|
2020
Q2 | $1.84M | Hold |
11,209
| – | – | 1.38% | 20 |
|
|
2020
Q1 | $1.55M | Hold |
11,209
| – | – | 1.07% | 30 |
|
|
2019
Q4 | $1.47M | Hold |
11,209
| – | – | 1.34% | 26 |
|
|
2019
Q3 | $1.25M | Hold |
11,209
| – | – | 1.18% | 20 |
|
|
2019
Q2 | $1.24M | Hold |
11,209
| – | – | 1.21% | 20 |
|
|
2019
Q1 | $1.45M | Sell |
11,209
-2
| -0% | -$243 | 1.21% | 18 |
|
|
2018
Q4 | $1.3M | Hold |
11,211
| – | – | 1.38% | 22 |
|
|
2018
Q3 | $1.2M | Hold |
11,211
| – | – | 0.79% | 35 |
|
|
2018
Q2 | $957K | Hold |
11,211
| – | – | 0.62% | 35 |
|
|
2018
Q1 | $867K | Sell |
11,211
-13,298
| -54% | -$1.07M | 0.61% | 37 |
|
|
2017
Q4 | $2.07M | Buy |
24,509
+1,128
| +5% | +$96K | 1.39% | 20 |
|
|
2017
Q3 | $2M | Buy |
23,381
+369
| +2% | +$30.3K | 1.45% | 18 |
|
|
2017
Q2 | $1.89M | Sell |
23,012
-6
| -0% | -$490 | 1.52% | 18 |
|
|
2017
Q1 | $1.94M | Buy |
23,018
+11,110
| +93% | +$890K | 1.68% | 20 |
|
|
2016
Q4 | $876K | Buy |
+11,908
| New | +$887K | 1.12% | 28 |
|
Other funds holding LLY
SC
ONB
GIM
WAM
Stableford Capital II's LLY Position: Q2 2026 in Review
Stableford Capital II reduced its Eli Lilly (LLY) stake by 5.4% in Q2 2026, selling an estimated $414K and leaving 7,098 shares worth $8.51M. The position accounts for 2.95% of the portfolio, ranked #8.
Stableford Capital II first reported a position in LLY in Q4 2016 and has held it in 38 quarters since. The position peaked at $9.16M in Q3 2024. 1,233 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Stableford Capital II held 7,098 shares of Eli Lilly worth $8.51M as of Q2 2026.
- Stableford Capital II sold 405 Eli Lilly shares in Q2 2026, an estimated $414K.
- Eli Lilly made up 2.95% of Stableford Capital II's portfolio in Q2 2026, its #8 holding.
- Stableford Capital II first reported a position in Eli Lilly in Q4 2016 and has held it in 38 quarters since.
- Stableford Capital II's Eli Lilly position peaked at $9.16M in Q3 2024.
- 1,233 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Stableford Capital II's 13F filing for Q2 2026, filed 6 Jul 2026.